ABCL:NASDAQ
AbCellera Biologics Inc
$12.70
arrow_upward
+0.40%(+0.050) 1D
$12.79
arrow_upward
+0.71% (+0.090)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABCL...
Open
$12.74
High
$12.93
Low
$12.29
Mkt. cap
4.11B
Avg. vol.
5.96M
Volume
3.38M
52-wk high
$13.18
52-wk low
$2.74
EPS
-$0.54
Beta
1.32
Shares outstanding
324.05M
No. of employees
562
Open
$12.74
High
$12.93
Low
$12.29
Mkt. cap
4.11B
Avg. vol.
5.96M
Volume
3.38M
52-wk high
$13.18
52-wk low
$2.74
EPS
-$0.54
Beta
1.32
Shares outstanding
324.05M
No. of employees
562
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com